Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Genentech (RHHBY)'s Breast Cancer Cocktail Buys More Than a Year of Life 2/20/2015 6:46:14 AM
Merck & Co. (MRK) Release: New Data From IMPROVE-IT Study Of VYTORIN® (Ezetimibe/Simvastatin) And TRA 2ºp TIMI 50 Study Of ZONTIVITY® (Vorapaxar) To Be Presented At American College of Cardiology Scientific Sessions 2/25/2015 11:02:59 AM
Regeneron (REGN)'s Eylea Beats Genentech (RHHBY) in Rare Face Off Over Some Vision Loss Cases 2/19/2015 6:11:14 AM
Celltrion Healthcare: Data Show The World’s First European Medicines Agency-Approved Biosimilar Monoclonal Antibody Remsima Could Reduce Cost Of Treating Crohn’s Disease By Up To €336 Million Over Five Years 2/20/2015 9:04:24 AM
Novartis AG (NVS) May Already Have First True Anti-Aging Drug in Its Pipeline 2/13/2015 6:19:20 AM
Regeneron (REGN) Release: NIH-Sponsored Comparative Effectiveness Trial In Diabetic Macular Edema Shows EYLEA (Aflibercept) Injection Demonstrated Significantly Greater Gains In Visual Acuity Than Both Bevacizumab And Ranibizumab 2/19/2015 6:12:29 AM
Pfizer (PFE)'s Chantix Effective for Smokers 2/18/2015 7:00:54 AM
New Study Vindicates Efficacy of Roche (RHHBY)'s Blockbuster Drug Tamiflu 1/30/2015 6:13:46 AM
Cumberland Pharmaceuticals (CPIX) Release: Phase IV Studies Published Supporting The Safety Of A Shortened Infusion Time Of Caldolor® (ibuprofen) Injection 2/2/2015 9:50:08 AM
AstraZeneca PLC (AZN)'s Brilinta Boosted by Major Clinical Trial Success 1/14/2015 5:50:03 AM
Ipsen (IPN.PA) To Present Further Data On Recently FDA-Approved Antitumor Therapy, Somatuline® Depot® (Lanreotide), At Gastrointestinal Cancers Symposium 1/13/2015 7:33:08 AM
DBV Technologies Announces Publication In The Journal Of Allergy And Clinical Immunology Of Data Demonstrating That Epicutaneous Immunotherapy May Influence The Natural History Of Allergy 1/12/2015 6:58:38 AM
Merck & Co. (MRK)'s Gardasil Not Linked To Multiple Sclerosis, JAMA Reveals 1/7/2015 6:39:21 AM
Cerulean Pharma Inc. (CERU) Announces Publication Describing Synergistic Anti-Tumor Activity Of CRLX101 With Avastin In Advanced Metastatic Ovarian Tumor Models 1/6/2015 11:06:56 AM
Soligenix (SNGX) Announces Publication of Combination Ricin/Anthrax Vaccine Data 12/29/2014 7:38:51 AM
1234567
//-->